Felzartamab Selectively and Potently Targets CD38+ Antibody-Secreting Cells from Patients with Immune-Mediated Kidney Diseases ; SA-PO721
| Title: | Felzartamab Selectively and Potently Targets CD38+ Antibody-Secreting Cells from Patients with Immune-Mediated Kidney Diseases ; SA-PO721 |
|---|---|
| Authors: | Delfino, Tess Arenzana; Ilieva, Kristina M.; Landgraf, Karin; Boxhammer, Rainer; Steidl, Stefan; Flesher, Donna |
| Source: | Journal of the American Society of Nephrology ; volume 35, issue 10S ; ISSN 1046-6673 1533-3450 |
| Publisher Information: | Ovid Technologies (Wolters Kluwer Health) |
| Publication Year: | 2024 |
| Document Type: | article in journal/newspaper |
| Language: | English |
| DOI: | 10.1681/asn.2024s1kbcs27 |
| DOI: | 10.1681/ASN.2024s1kbcs27 |
| Availability: | https://doi.org/10.1681/asn.2024s1kbcs27; https://journals.lww.com/10.1681/ASN.2024s1kbcs27 |
| Accession Number: | edsbas.6B08B422 |
| Database: | BASE |